<DOC>
	<DOCNO>NCT00494533</DOCNO>
	<brief_summary>Multi-center , double-blind , placebo-controlled , randomize , parallel study compare continuous intravenous ( IV ) Remodulin® placebo patient pulmonary arterial hypertension either primary ( PPH ) associate human immunodeficiency virus ( HIV ) infection collagen vascular disease ) .</brief_summary>
	<brief_title>Study Intravenous Remodulin Patients India With Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Treprostinil</mesh_term>
	<criteria>Patients Must 1 . Between 16 75 year age . 2 . Male , female , physiologically incapable childbearing utilizing birth control . 3 . Have current diagnosis symptomlimited NYHA Functional Class III/IV PAH : PPH ( `` idiopathic '' familial PAH ) ; PAH associate collagen vascular disease ( confirm antinuclear antibody titer acceptable test ) ; PAH associate HIV infection ( confirmed serological test ) . 4 . If HIV positive , CD4 lymphocyte count ≥ 200 baseline receive current SOC antiretroviral effective medication HIV infection . 5 . Optimally treated conventional PH therapy clinically stable least 1 month prior baseline . 6 . Have ventilation/perfusion scan , contrastenhanced CT scan , pulmonary angiogram onset PAH rule pulmonary embolism . 7 . Have cardiac catheterization last 3 month ( Baseline ) showing : PAPm &gt; 35 mmHg ( rest ) &amp; PCWPm ( LV end diastolic pressure ) &lt; 16 mmHg &amp; PVR &gt; 5 mmHg/L/min . 8 . Have echocardiogram last 3 month consistent PH , specifically : evidence RV hypertrophy dilation &amp; evidence normal LV function &amp; absence mitral valve stenosis . 9 . Have chest radiograph consistent PH perform last 3 month . Radiograph must show clear lung field patchy interstitial infiltrates . 10 . Unless contraindicate , able receive one follow anticoagulant : warfarin achieve INR 1.52.5 heparin produce aPTT 1.31.5 time control , unless high level clinically indicate . 11 . Mentally physically capable learn administer Study Drug use ambulatory intravenous infusion pump central venous access , train caregiver . 12 . If corticosteroid , receive stable dose 20 mg/day prednisone ( equivalent dose another steroid ) least 1 month prior entry . Patients must : 1 . Nursing pregnant ( woman childbearing potential negative pregnancy test ) . 2 . Have new type chronic therapy ( include limit oxygen , different category vasodilator , diuretic , digoxin ) PH , except anticoagulant , add last month . 3 . Be schedule heartlung transplant . 4 . Have PH medication except anticoagulant discontinue week prior study entry . 5 . Have receive chronic prostaglandin prostaglandin analogue ( include intravenous/inhaled/oral : epoprostenol , iloprost , beraprost , etc . ) , phosphodiesterase inhibitor therapy sildenafil , endothelin antagonist therapy bosentan , past 30 day . 6 . Have PH associate chronic thromboembolic disease ; chronic obstructive lung disease hypoxemia ; evidence significant parenchymal lung disease evidence PFTs last 3 month follow ( one follow ) : TLC &lt; 60 % ( predict ) high resolution CT documenting diffuse interstitial fibrosis alveolitis FEV1/FVC ratio &lt; 50 % 7 . Have Portal Hypertension . 8 . Have history uncontrolled Sleep Apnea , define oxygen desaturation le 90 % night , past 3 month . 9 . Have history leftsided heart disease include : Aortic mitral valve disease Pericardial constriction Restrictive congestive cardiomyopathy ; evidence current leftsided heart disease define : PCWPm LV end diastolic pressure &gt; 16 mmHg LVEF &lt; 40 % MUGA , angiography echocardiography LV Shortening Fraction &lt; 22 % echocardiography Symptomatic coronary disease ( demonstrable ischemia ) . 10 . Have disease HIV connective tissue disease associate PH ( e.g . sickle cell anemia , schistosomiasis ) . 11 . Have active AIDS tuberculosis . 12 . Have musculoskeletal disorder ( e.g . arthritis , artificial leg , etc . ) disease think limit ambulation , connect machine portable . 13 . Have baseline exercise capacity &lt; 50 &gt; 325 measure 6Minute Walk Test . 14 . Have uncontrolled systemic hypertension evidence systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 100 mmHg . 15 . Have use prescription appetite suppressant 3 month study entry . 16 . Have chronic renal insufficiency define creatinine &gt; 2.5 mg/dL require dialysis . 17 . Receiving investigational drug ( acute challenge epoprostenol ) , place investigational device , participate investigational drug/device study past 30 day . 18 . Have presence physiological mental condition contraindicates administration Remodulin .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>pulmonary arterial hypertension</keyword>
	<keyword>prostacyclin analogue</keyword>
	<keyword>intravenous</keyword>
</DOC>